Home › Funds › Nan Fung Group Holdings Ltd › LBRX
Nan Fung Group Holdings Ltd position in LBRX
LB PHARMACEUTICALS INC · Health Care
Nan Fung Group Holdings Ltd reported holding 630,657 shares of LBRX (LB PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$24.2M, representing 16.35% of its reported portfolio and ranking #1 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Nan Fung Group Holdings Ltd's LBRX position evolved
Nan Fung Group Holdings Ltd first disclosed a stake in LBRX in Q3 2025 at 300,000 shares (US$4.7M). The position peaked in Q3 2026 at 630,657 shares, worth US$24.2M. Across 5 filings, Nan Fung Group Holdings Ltd increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 630,657 shares valued at US$24.2M. Notable position changes include a 110% increase in Q1 2026 (shares rose 32% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 300.00K | $4.74M | New |
| Q4 2025 | 300.00K | $6.68M | Hold |
| Q1 2026 | 630.66K | $15.55M | Add |
| Q2 2026 | 630.66K | $20.47M | Hold |
| Q3 2026 | 630.66K | $24.20M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LBRX and 13F data
LBRX (LB PHARMACEUTICALS INC) is a Health Care company. 106 other funds we track also report a position in LBRX — the largest reported positions include Deep Track Capital, LP (US$108.8M), RA CAPITAL MANAGEMENT, L.P. (US$71.7M), Spruce Street Capital LP (US$53.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LBRX
- Deep Track Capital, LP 3.35M sh · $108.82M · Q2 2026
- RA CAPITAL MANAGEMENT, L.P. 2.21M sh · $71.68M · Q2 2026
- Spruce Street Capital LP 1.40M sh · $53.86M · Q3 2026
- Trails Edge Capital Partners, LP 1.52M sh · $49.43M · Q2 2026
- Commodore Capital LP 1.50M sh · $48.68M · Q2 2026
- TCG Crossover Management, LLC 1.45M sh · $46.97M · Q2 2026
- Caligan Partners LP 1.44M sh · $46.67M · Q2 2026
- Nantahala Capital Management, LLC 1.07M sh · $41.23M · Q3 2026
- Vivo Capital, LLC 800.00K sh · $30.70M · Q3 2026
- Logos Global Management LP 585.00K sh · $18.99M · Q2 2026
- GREAT POINT PARTNERS LLC 317.22K sh · $10.30M · Q2 2026
- HighVista Strategies LLC 173.80K sh · $6.67M · Q3 2026
More on Nan Fung Group Holdings Ltd
FAQ
How long has Nan Fung Group Holdings Ltd held LBRX?
Nan Fung Group Holdings Ltd has disclosed LBRX holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Nan Fung Group Holdings Ltd's current position in LBRX?
As of Q3 2026, Nan Fung Group Holdings Ltd holds 630.66K shares of LBRX (LB PHARMACEUTICALS INC), valued at $24.20M, representing 16.35% of its reported portfolio and ranking #1.
Has Nan Fung Group Holdings Ltd been buying or selling LBRX?
In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in LBRX. The position peaked in Q3 2026 at 630.66K shares.
Which other funds hold LBRX?
Other major institutional holders of LBRX include Deep Track Capital, LP, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, among 106 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.